Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBP) CpG island in breast cancer is associated with metastatic relapse

British Journal of Cancer

Volumn 107, Issue 4, 2012, Pages 732-738

  Palmieri, C ^a   Monteverde, M ^b   Lattanzio, L ^b   Gojis, O ^a,c   Rudraraju, B ^a   Fortunato, M ^b   Syed, N ^d   Thompson, A ^e   Garrone, O ^b   Merlano, M ^b   Lo Nigro, C ^b   Crook, T ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c CHARLES UNIVERSITY   (Czech Republic)

^d CHARING CROSS HOSPITAL   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

breast cancer; CEBPD; metastasis; methylation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; GENOMIC DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RELAPSE; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PYROSEQUENCING; RECEPTOR DOWN REGULATION; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84864875362     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.308     Document Type: Article

References (30)

1. Agrawal S, Hofmann WK, Tidow N, Ehrich M, van den Boom D, Koschmieder S, Berdel WE, Serve H, Müller-Tidow C (2007) The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 109: 3895-3905
2. Balamurugan K, Wang JM, Tsai HH, Sharan S, Anver M, Leighty R, Sterneck E (2010) The tumour suppressor C/EBPd inhibits FBXW7 expression and promotes mammary tumour metastasis. EMBO J 29: 4106-4117
3. Barresi V, Vitarelli E, Cerasoli S, Barresi G (2009) The cell growth inhibitory transcription factor C/EBPdelta is expressed in human meningiomas in association with low histological grade and proliferation index. J Neurooncol 97: 233-240
4. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van der Vijver MJ, Gerald WL, Foekens JA, Massague J (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009
5. Cooper C, Henderson A, Artandi S, Avitahl N, Calame K (1995) Ig/EBP(C/EBPd) is a transdominant negative inhibitor of C/EBP family of transcriptionalactivators. Nucleic Acids Res 23: 4371-4377
6. Gery S, Tanosaki S, Hofmann WK, Koppel A, Koeffler HP (2005) C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation. Oncogene 24: 1589-1597
7. Gigliotti AP, Johnson PF, Sterneck E, DeWille JW (2003) Nulliparous CCAAT/enhancer binding proteindelta (C/EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia. Exp Biol Med 228: 278-285
8. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578-10582
9. Ikezoe T, Gery S, Yin D, O'Kelly J, Binderup L, Lemp N, Taguchi H, Koeffler HP (2005) CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitaminD3 in androgen-responsive prostate cancer LNCaP cells. Cancer Res 2005 65 4762-4768
10. Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28: 3271-3277
11. Ko C-Y, Hsu H-C, Shen M-R, Chang W-C, Wang J-M (2008) Epigenetic silencing of CCAAT Enhancer-binding Protein d activity by YY1/Polycomb Group/DNA methyltransferase complex. J Biol Chem 283: 30919-30932
12. Kuramoto T, Morimura K, Yamashita S, Okochi E, Watanabe N, Ohta T, Ohki M, Fukushima S, Sugimura T, Ushijima T (2002) Etiology-specific gene expression profiles in rat mammary carcinomas. Cancer Res 62: 3592-3597
13. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, Powe DG, Robertson JF, Aparicio S, Ellis IO, Brenton JD, Caldas C (2007) A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26: 1507-1516
14. O'Rourke J, Yuan R, DeWille J (1997) CCAAT/enhancer-binding protein delta (C/EBP-delta) is induced in growth-arrested mouse mammary epithelial cells. J Biol Chem 272: 6291-6296
15. Osada S, Yamamoto H, Nishihara T, Imagwa M (1997) DNA binding specifcity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem 271: 3891-3896
16. Palmieri C, Rudraraju B, Monteverde M, Lattanzio L, Gojis O, Brizio R, Garrone O, Merlano M, Syed N, Lo Nigro C, Crook T (2012) Methylation of the calcium channel regulatory subunit a2d-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas. Br J Cancer; e-pub ahead of print 29 May; doi:10.1038/bjc.2012.231
17. Pawar SA, Roy Sarkar T, Balamurugan K, Sharan S, Wang J, Zhang Y, Dowdy SF, Huang AM, Sterneck E (2010) C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proc Natl Acad Sci USA 107: 9210-9215
18. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K (2003) Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 1: 362-375
19. Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K (2001) A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 61: 5697-5702
20. Ramji DP, Foka P (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575
21. Shah R, Smith P, Purdie C, Quinlan P, Baker L, Aman P, Thompson AM, Crook T (2009) The Prolyl 3-Hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br J Cancer 100: 1687-1696
22. Stein T, Salomonis N, Nuyten DS, van de Vijver MJ, Gusterson BA (2009) A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis. J Mammary Gland Biol Neoplasia 14: 99-116
23. Sivko GS, DeWille JW (2004) CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells I. 'Loss of function' alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines. J Cell Biochem 93: 830-843
24. Tang D, Sivko GS, DeWille JW (2006) Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors. Breast Cancer Res Treat 95: 161-170
25. Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, Hennighausen L, Huang A-M, Sterneck E (2005) C/EBPd is a crucial regulator of proapoptotic gene expression during mammary gland involution. Development 132: 4675-4685
26. Robinson GW, Johnson PF, Hennighausen L, Sterneck E (1998) The C/EBPb transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev 12: 1907-1916
27. Vinson C, Myakishev M, Acharya A, Mir AA, Moll JR, Bonovich M (2002) Classification of human B-ZIP proteins based on dimerization properties. Mol Cell Biol 22: 6321-6335
28. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ (1995) Impaired energy homeostasis in C/EBPa knockout mice. Science 269: 1108-1112
29. Yamanaka R, Kim GD, Radomska HS, Lekstrom-Himes J, Smith LT, Antonson P, Tenen DG, Xanthopoulos KG (1997) CCAAT/enhancer binding protein e is preferentially up-regulated during granulocyte differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci USA 94: 6462-6467
30. Zinszner H, Kuroda M, Wang X-Z, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12: 982-995